Emeren Group (SOL) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for November 1, 2024, with key items including director appointments, executive compensation, auditor ratification, and shareholder proposals.

• Shareholders of record as of September 17, 2024, are entitled to vote; 512,549,555 Common Shares outstanding, each with one vote.

• Proxy materials and annual report are available online; voting can be done in person, by proxy, or via teleconference.

Voting matters and shareholder proposals

• Proposals include appointing Dr. Ramakrishnan Srinivasan as director, re-electing Martin Bloom and Yumin Liu, advisory vote on executive compensation, advisory vote on frequency of say-on-pay, and ratification of UHY LLP as auditor.

• Advisory votes on executive compensation and its frequency are non-binding but will be considered by the Board.

• Shareholder proposals for the 2025 meeting must be received by May 20, 2025.

Board of directors and corporate governance

• Board consists of six directors; majority are independent per NYSE standards.

• Board committees: Audit, Compensation, Nominating and Corporate Governance, and ESG, each with formal charters.

• Board separation of CEO and Chairman roles; regular review of governance guidelines and code of conduct.

• Directors expected to attend at least 75% of meetings and the annual meeting.